The computational model predicted that melanoma cells could become insensitive to both cytostatic and genotoxic drugs when displaying a signature of combined high expression for the E2F1 TF, low for miRNA-205 and high expression for the ERBB3 receptor, three of the molecular factors included in the intracellular regulatory network of the model. Here, E2F1 is linked to melanoma.